Search details
1.
Characterization of an in vitro model to study the possible role of polyomavirus BK in prostate cancer.
J Cell Physiol
; 234(7): 11912-11922, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30515818
2.
Polyomavirus BK and prostate cancer: a complex interaction of potential clinical relevance.
Rev Med Virol
; 25(6): 366-78, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26308483
3.
New insights on the association between the prostate cancer and the small DNA tumour virus, BK polyomavirus.
J Transl Med
; 13: 387, 2015 Dec 23.
Article
in English
| MEDLINE | ID: mdl-26699530
4.
High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.
Med Sci Monit
; 21: 2266-74, 2015 Aug 04.
Article
in English
| MEDLINE | ID: mdl-26241709
5.
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia.
J Virol
; 86(16): 8461-71, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22647697
6.
Myoblasts inhibit prostate cancer growth by paracrine secretion of tumor necrosis factor-α.
J Urol
; 189(5): 1952-9, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23123370
7.
Harnessing systemic immune responses for polyomavirus BK involvement in cancer development and progression.
Cytokine
; 96: 273, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28527410
8.
Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer.
Cancers (Basel)
; 14(5)2022 Feb 23.
Article
in English
| MEDLINE | ID: mdl-35267445
9.
Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.
J Transl Med
; 9: 162, 2011 Sep 26.
Article
in English
| MEDLINE | ID: mdl-21943235
10.
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.
BMC Cancer
; 10: 341, 2010 Jun 30.
Article
in English
| MEDLINE | ID: mdl-20591150
11.
The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice.
Front Immunol
; 11: 1244, 2020.
Article
in English
| MEDLINE | ID: mdl-32922383
12.
A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.
J Cell Mol Med
; 13(8B): 2131-2147, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19604317
13.
T cell epitope-mapping by cytokine gene expression assay.
Methods Mol Biol
; 514: 107-18, 2009.
Article
in English
| MEDLINE | ID: mdl-19048216
14.
Gene expression signatures of interleukin-2 in vivo and in vitro and their relation to anticancer therapy.
Crit Rev Immunol
; 27(5): 437-48, 2007.
Article
in English
| MEDLINE | ID: mdl-18197806
15.
Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression.
Front Immunol
; 9: 1051, 2018.
Article
in English
| MEDLINE | ID: mdl-29896191
16.
MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.
Trends Mol Med
; 12(10): 465-72, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-16962375
17.
Complementary techniques: validation of gene expression data by quantitative real time PCR.
Adv Exp Med Biol
; 593: 66-73, 2007.
Article
in English
| MEDLINE | ID: mdl-17265717
18.
Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
Exp Hematol
; 34(3): 296-307, 2006 Mar.
Article
in English
| MEDLINE | ID: mdl-16543064
19.
Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
Oncotarget
; 8(13): 21871-21883, 2017 Mar 28.
Article
in English
| MEDLINE | ID: mdl-28423532
20.
Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets.
J Transl Med
; 4: 26, 2006 Jun 28.
Article
in English
| MEDLINE | ID: mdl-16805915